Considering these findings, further studies are required in order to fully understand the implications of IL-6 in the pathogenesis of HTN and its end-organ damage and the possible development of new antihypertensive drugs targeting inflammatory cytokines [127]. The gene discussed is IL6; the disease is hypertensive disorder.